ADAMS ADRIAN
SEC CIK 1248144 · EDGAR
Most active insiders at TLPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Angotti Vincent J. | CEO, Dir | $211.2K | — |
| 2 | ASADORIAN RAFFI | CFO | $36.5K | — |
| 3 | Aslam Shakil | Chief Medical Off | $28.4K | — |
| 4 | Dasu Badri N | Chief Engineering Off | $28.4K | — |
| 5 | JAIN ABHINAV | Dir | — | — |
| 6 | Bozilenko Marina | Dir | — | — |
| 7 | Todisco Joseph | Dir | — | — |
| 8 | Broadfoot Jill Marie | Dir | — | — |
| 9 | ADAMS ADRIAN | Dir | — | — |
| 10 | WAN MARK A | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-24 17:07 | 2026-06-22 | TLPH | TALPHERA, INC. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +5,100 | 22.7K | +29% | $0 |
| D | 2026-06-22 16:09 | 2026-06-17 | AKBA | Akebia Therapeutics, Inc. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +35.7K | 236.2K | +18% | $0 |
| D | 2025-10-24 | 2025-10-23 | TLPH | TALPHERA, INC. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +4,267 | 17.6K | +32% | $0 |
| D | 2025-06-11 | 2025-06-10 | AKBA | Akebia Therapeutics, Inc. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +35.7K | 200.5K | +22% | $0 |
| D | 2024-06-24 | 2024-06-24 | TLPH | TALPHERA, INC. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +2,174 | 13.3K | +19% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | Akebia Therapeutics, Inc. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +30.0K | 164.8K | +22% | $0 |
| D | 2023-12-13 | 2023-10-10 | TLPH | TALPHERA, INC. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +581 | 11.2K | +5% | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | Akebia Therapeutics, Inc. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +30.0K | 134.8K | +29% | $0 |
| D | 2022-07-15 | 2022-07-15 | TLPH | TALPHERA, INC. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +15.5K | 211.8K | +8% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | Akebia Therapeutics, Inc. | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +13.7K | 104.8K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations